ICON Net Profit Margin 2010-2023 | ICLR
ICON Net Profit Margin Historical Data | |||
---|---|---|---|
Date | TTM Revenue | TTM Net Income | Net Margin |
2023-12-31 | $8.12B | $0.61B | 7.55% |
2023-09-30 | $8.02B | $0.51B | 6.41% |
2023-06-30 | $7.90B | $0.51B | 6.45% |
2023-03-31 | $7.82B | $0.51B | 6.52% |
2022-12-31 | $7.74B | $0.51B | 6.52% |
2022-09-30 | $7.66B | $0.46B | 6.05% |
2022-06-30 | $7.59B | $0.21B | 2.77% |
2022-03-31 | $6.52B | $0.17B | 2.58% |
2021-12-31 | $5.48B | $0.15B | 2.79% |
2021-09-30 | $4.36B | $0.18B | 4.09% |
2021-06-30 | $3.19B | $0.36B | 11.41% |
2021-03-31 | $2.94B | $0.34B | 11.50% |
2020-12-31 | $2.80B | $0.33B | 11.91% |
2020-09-30 | $2.76B | $0.33B | 11.98% |
2020-06-30 | $2.77B | $0.33B | 12.06% |
2020-03-31 | $2.85B | $0.38B | 13.29% |
2019-12-31 | $2.81B | $0.37B | 13.33% |
2019-09-30 | $2.76B | $0.36B | 13.16% |
2019-06-30 | $2.70B | $0.35B | 13.05% |
2019-03-31 | $2.65B | $0.33B | 12.56% |
2018-12-31 | $2.60B | $0.32B | 12.44% |
2018-09-30 | $2.37B | $0.31B | 12.90% |
2018-06-30 | $2.16B | $0.30B | 13.68% |
2018-03-31 | $1.95B | $0.29B | 14.80% |
2017-12-31 | $1.76B | $0.28B | 15.98% |
2017-09-30 | $1.74B | $0.28B | 16.34% |
2017-06-30 | $1.72B | $0.27B | 15.95% |
2017-03-31 | $1.70B | $0.27B | 15.90% |
2016-12-31 | $1.67B | $0.26B | 15.72% |
2016-09-30 | $1.64B | $0.25B | 15.41% |
2016-06-30 | $1.61B | $0.25B | 15.53% |
2016-03-31 | $1.59B | $0.25B | 15.62% |
2015-12-31 | $1.58B | $0.24B | 15.30% |
2015-09-30 | $1.56B | $0.23B | 14.79% |
2015-06-30 | $1.56B | $0.22B | 14.08% |
2015-03-31 | $1.54B | $0.20B | 13.04% |
2014-12-31 | $1.50B | $0.18B | 12.03% |
2014-09-30 | $1.46B | $0.16B | 10.97% |
2014-06-30 | $1.41B | $0.14B | 9.78% |
2014-03-31 | $1.37B | $0.12B | 8.69% |
2013-12-31 | $1.44B | $0.10B | 7.09% |
2013-09-30 | $1.39B | $0.09B | 6.46% |
2013-06-30 | $1.34B | $0.08B | 5.97% |
2013-03-31 | $1.28B | $0.07B | 5.54% |
2012-12-31 | $1.21B | $0.06B | 5.06% |
2012-09-30 | $1.15B | $0.04B | 3.83% |
2012-06-30 | $1.10B | $0.02B | 2.08% |
2012-03-31 | $1.06B | $0.02B | 2.17% |
2011-12-31 | $1.02B | $0.02B | 2.15% |
2011-09-30 | $1.01B | $0.04B | 3.95% |
2011-06-30 | $1.00B | $0.06B | 6.33% |
2011-03-31 | $0.99B | $0.07B | 7.40% |
2010-12-31 | $0.99B | $0.09B | 8.78% |
2010-09-30 | $0.99B | $0.10B | 9.74% |
2010-06-30 | $0.98B | $0.10B | 10.19% |
2010-03-31 | $0.98B | $0.10B | 9.83% |
2009-12-31 | $0.89B | $0.10B | 10.71% |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Services | $27.616B | $8.120B |
ICON plc is a global full service clinical research organisation. The company provides contract clinical research services to the pharmaceutical industry worldwide. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Elevance Health (ELV) | United States | $119.394B | 15.50 |
Cencora (COR) | United States | $47.523B | 18.97 |
DiDi Global (DIDIY) | China | $18.703B | 0.00 |
Avantor (AVTR) | United States | $17.011B | 23.44 |
Viatris (VTRS) | United States | $14.324B | 4.09 |
CochLear (CHEOY) | $14.284B | 0.00 | |
Charles River Laboratories (CRL) | United States | $13.285B | 24.32 |
Revvity (RVTY) | United States | $12.958B | 22.56 |
Medpace Holdings (MEDP) | United States | $12.204B | 44.68 |
EUROFINS SCIENT (ERFSF) | Luxembourg | $11.925B | 0.00 |
Natera (NTRA) | United States | $10.810B | 0.00 |
HealthEquity (HQY) | United States | $6.988B | 61.70 |
Amplifon S.p.A (AMFPF) | Italy | $6.762B | 34.33 |
Bausch + Lomb (BLCO) | Canada | $5.598B | 21.55 |
Doximity (DOCS) | United States | $5.201B | 38.72 |
Organon (OGN) | United States | $4.673B | 4.52 |
Sotera Health (SHC) | United States | $4.107B | 20.17 |
Surgery Partners (SGRY) | United States | $3.605B | 33.49 |
Progyny (PGNY) | United States | $3.394B | 56.73 |
Life Times (LTH) | United States | $2.779B | 30.72 |
GoodRx Holdings (GDRX) | United States | $2.729B | 138.20 |
Premier (PINC) | United States | $2.532B | 9.27 |
Teladoc Health (TDOC) | United States | $2.526B | 0.00 |
AMN Healthcare Services Inc (AMN) | United States | $2.225B | 7.20 |
Agilon Health (AGL) | United States | $2.179B | 0.00 |
NovoCure (NVCR) | Jersey | $1.497B | 0.00 |
BrightSpring Health Services (BTSG) | United States | $1.411B | 0.00 |
Agiliti (AGTI) | United States | $1.351B | 22.13 |
Establishment Labs Holdings (ESTA) | $1.333B | 0.00 | |
Alignment Healthcare (ALHC) | United States | $0.943B | 0.00 |
Pediatrix Medical (MD) | United States | $0.797B | 8.24 |
Embecta (EMBC) | United States | $0.762B | 5.03 |
COMPASS Pathways (CMPS) | United Kingdom | $0.613B | 0.00 |
InnovAge Holding (INNV) | United States | $0.583B | 0.00 |
Enhabit (EHAB) | United States | $0.552B | 50.04 |
CareDx (CDNA) | United States | $0.525B | 0.00 |
Beauty Health (SKIN) | United States | $0.474B | 0.00 |
MultiPlan (MPLN) | United States | $0.457B | 0.00 |
ModivCare (MODV) | United States | $0.415B | 5.50 |
QDM (QDMI) | Hong Kong, SAR China | $0.408B | 10.69 |
LifeMD (LFMD) | United States | $0.407B | 0.00 |
DocGo (DCGO) | United States | $0.381B | 61.00 |
Sharecare (SHCR) | United States | $0.345B | 0.00 |
GeneDx Holdings (WGS) | United States | $0.313B | 0.00 |
Sera Prognostics (SERA) | United States | $0.290B | 0.00 |
Ascend Wellness Holdings (AAWH) | United States | $0.240B | 0.00 |
Sonida Senior Living (SNDA) | United States | $0.214B | 0.00 |
Biodesix (BDSX) | United States | $0.143B | 0.00 |
Oncology Institute (TOI) | United States | $0.124B | 0.00 |
So-Young (SY) | China | $0.100B | 25.00 |
Pono Capital Two (PTWO) | United States | $0.067B | 0.00 |
Nutex Health (NUTX) | United States | $0.065B | 0.00 |
NeueHealth (NEUE) | United States | $0.061B | 0.00 |
IceCure Medical (ICCM) | Israel | $0.055B | 0.00 |
SeaStar Medical Holding (ICU) | United States | $0.047B | 0.00 |
Singular Genomics Systems (OMIC) | United States | $0.037B | 0.00 |
TRxADE HEALTH (MEDS) | United States | $0.035B | 0.00 |
Co-Diagnostics (CODX) | United States | $0.033B | 0.00 |
BIMI Medical (BIMI) | United States | $0.033B | 0.00 |
NeuroOne Medical Technologies (NMTC) | United States | $0.027B | 0.00 |
OncoCyte (OCX) | United States | $0.025B | 0.00 |
DermTech (DMTK) | United States | $0.024B | 0.00 |
BioNexus Gene Lab (BGLC) | $0.013B | 0.00 | |
Aesthetic Medical Hldngs Group (AIH) | China | $0.010B | 0.00 |
Intelligent Bio Solutions (INBS) | United States | $0.010B | 0.00 |
XWELL (XWEL) | United States | $0.008B | 0.00 |
OpGen (OPGN) | United States | $0.005B | 0.00 |
Assure Holdings (IONM) | United States | $0.004B | 0.00 |
ISpecimen (ISPC) | United States | $0.003B | 0.00 |
Aclarion (ACON) | United States | $0.001B | 0.00 |